DJIA 18,126.12 -36.87 -0.20%
NASDAQ 5,097.98 -8.62 -0.17%
S&P 500 2,120.79 -2.69 -0.13%
market minute promo


3.58 0.26 (7.83%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

XOMA $3.58 7.83%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $3.42
Previous Close $3.32
Daily Range $3.31 - $3.67
52-Week Range $2.92 - $5.95
Market Cap $421.8M
P/E Ratio -5.11
Dividend (Yield) $0.00 (0.0%)
Volume 9,510,974
Average Daily Volume 2,059,473
Current FY EPS -$0.65




Drug Makers

XOMA Limited (XOMA) Description

A biopharmaceutical company that discovers, develops and manufactures antibodies and other genetically-engineered protein products to treat immunological and inflammatory disorders, cancer and infectious diseases. Website:

News & Commentary Rss Feed

Why XOMA Corp. Shares Rocketed Higher

XOMA shareholders press the launch button after the company begins the (approximate) countdown to a major news event.

XOMA Stock Gains on Poisitive Phase 3 Study Results of Behcet's Disease Treatment

How 1 Sentence Caused XOMA Corp. Shares to Explode Higher

XOMA Corp. released its first-quarter earnings results after the closing bell last night, but it was a single sentence from management, not its actually quarterly results, that has investors so excited today.

Friday's ETF Movers: XBI, FM

Morning Market Gainers

Benzinga's Top #PreMarket Gainers

XOMA'S (XOMA) CEO John Varian on Q1 2015 Results - Earnings Call Transcript

XOMA (XOMA) Q1 2015 Results - Earnings Call Webcast

Credit Suisse Analysts Assume Coverage On 10 Biotech Stocks

3 Biotech Stocks With Big Phase 3 Catalyst Data Due in 2015

See More XOMA News...

XOMA's Top Competitors

XOMA $3.58 (7.83%)
Current stock: XOMA
AMGN $157.35 (-1.93%)
Current stock: AMGN
GILD $112.85 (0.35%)
Current stock: GILD
BIIB $400.10 (-0.70%)
Current stock: BIIB